Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2013
11/19/2013US8586329 Neurotoxins exhibiting shortened biological activity
11/19/2013US8586317 Methods of diagnosing hypophosphatemic disorders
11/19/2013US8586081 Detoxified recombinant botulinum neurotoxin
11/19/2013US8586059 Cattle vaccines
11/19/2013US8586058 Method for producing multiple modifications in the chromosome of gram-negative bacteria and salmonella strains which are deficient in c-di-GMP synthesis obtained by said method
11/19/2013US8586057 Enterohemorrhagic Escherichia coli vaccine
11/19/2013US8586056 HIV-1 envelope glycoprotein
11/19/2013US8586055 DNA immunization protocols
11/19/2013US8586052 Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cells
11/19/2013US8586051 Glycolipids and analogues thereof as antigens for NKT cells
11/19/2013US8586050 Combining radioimmunotherapy and antibody-drug conjugates for improved cancer therapy
11/19/2013US8586048 G-CSF immunoglobulin fusion proteins
11/19/2013US8586047 Genetic products differentially expressed in tumors and the use thereof
11/19/2013US8586046 Methods and compositions for mycoplasma pneumoniae exotoxins
11/19/2013US8586045 Methods of using anti-CGRP antagonist antibodies
11/19/2013US8586044 Treatment of chronic pelvic pain syndrome
11/19/2013US8586043 Methods for treating breast cancer with inhibitors of neurotensin activation of NTSR1
11/19/2013US8586042 Hybridomas producing monoclonal anti-mortalin peptide antibodies
11/19/2013US8586041 Human monoclonal antibodies to epidermal growth factor receptor (EGFR)
11/19/2013US8586040 Methods of using apoptotic anti-IGE antibodies
11/19/2013US8586038 Chimeric immunoglobulin fusion proteins
11/19/2013US8586037 Antibodies against IL-17BR
11/19/2013US8586036 Methods for the treatment of IL-1β related diseases
11/19/2013US8586035 Use of IL-23 antagonists for treatment of infection
11/19/2013US8586034 Cytomegalovirus disintegrin-like peptides
11/19/2013US8586033 Integrin αIIbβ3 specific antibodies and peptides
11/19/2013US8586025 Method of inhibiting methanogenesis
11/19/2013US8586022 Light emitting microorganisms and cells for diagnosis and therapy of tumors
11/19/2013CA2707235C Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin
11/19/2013CA2592366C Recombinant foot and mouth disease vaccine
11/19/2013CA2587507C Electroporation of mycobacterium and overexpression of antigens in mycobacteria
11/19/2013CA2560283C Antibodies as growth promoting agents
11/19/2013CA2512188C Immunotherapy of b cell malignancies and autoimmune disease using unconjugated antibodies and conjugated antibodies, antibody combinations and fusion proteins
11/19/2013CA2497582C Prophylaxis and treatment of infectious diseases
11/19/2013CA2496213C Metalloprotease activation of myostatin, and methods of modulating myostatin activity
11/19/2013CA2486450C Chimaeric human papillomavirus 16 l1 virus-like particles and method for preparing the particles
11/19/2013CA2473987C Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases
11/19/2013CA2447139C Specific binding proteins and uses thereof
11/19/2013CA2442684C Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors
11/19/2013CA2425842C Use of il-1 inhibitors and tnf antagonists, partially in combination with recombinant erythropoietins, for the treatment of anemia
11/19/2013CA2375800C Vaccine against isa virus
11/19/2013CA2353866C Treatment of papillomavirus infections
11/19/2013CA2329757C Use of .alpha.1.beta.1 integrin receptor inhibitors and tgf-.beta.1 inhibitors in the treatment of kidney disease
11/19/2013CA2305620C Method for the covalent attachment of polysaccharides to protein molecules
11/19/2013CA2290220C An infectious cdna clone of north american porcine reproductive and respiratory syndrome (prrs) virus and uses thereof
11/14/2013WO2013170263A2 Dosage and administration of bispecific scfv conjugates in combination with anti-cancer therapeutics
11/14/2013WO2013170221A1 Use of semaphorin-4d binding molecules to promote neurogenesis following stroke
11/14/2013WO2013170191A1 Methods of using antagonists of nad biosynthesis from nicotinamide
11/14/2013WO2013170154A1 Mycobacterium tuberculosis δesx-3 mutants
11/14/2013WO2013170139A1 Novel ha binding agents
11/14/2013WO2013170022A1 Biofilm prevention, disruption and treatment with bacteriophage lysin
11/14/2013WO2013170015A1 Bacteriophage lysin and antibiotic combinations against gram positive bacteria
11/14/2013WO2013169982A2 Mena and alpha5 integrin interaction
11/14/2013WO2013169961A1 Conformationally specific viral immunogens
11/14/2013WO2013169886A1 Anti-pcsk9 antibodies and use thereof
11/14/2013WO2013169829A2 Method of treating cancer
11/14/2013WO2013169693A1 Methods of treating cancer using an il-21 polypeptide and an anti-pd-1 antibody
11/14/2013WO2013169611A1 Compositions and methods for treating breast cancer
11/14/2013WO2013169377A1 Agents for influenza neutralization
11/14/2013WO2013168965A2 Vaccine composition for preventing staphylococcus aureus infection
11/14/2013WO2013168918A1 Anti-erbb2 antibody variants
11/14/2013WO2013168829A1 Anti oncostatin m receptor beta antibody
11/14/2013WO2013168826A1 Method for screening for prophylactic or therapeutic agent for diseases or disorders associated with inflammation-related feedback loop
11/14/2013WO2013168820A1 Anti-cxadr antibody
11/14/2013WO2013168174A1 Apoe4 antibodies for treatment of neurodegenerative conditions
11/14/2013WO2013167897A1 Hydrochloride salt of peptide and its use in combination with other peptides for immunotherapy
11/14/2013WO2013167720A1 Crystallization methods for purification of monoclonal antibodies
11/14/2013WO2013167156A1 Transplantation of modified monocytes
11/14/2013WO2013167130A1 177-Lu LABELED PEPTIDE FOR SITE-SPECIFIC uPAR-TARGETING
11/14/2013WO2013166681A1 Composition for producing microcapsules and medicine made thereof
11/14/2013WO2013166609A1 Rotavirus-like particle production in plants
11/14/2013WO2013166604A1 Single-arm monovalent antibody constructs and uses thereof
11/14/2013WO2013166594A1 Heteromultimer constructs of immunoglobulin heavy chains with mutations in the fc domain
11/14/2013WO2013151662A3 Therapies, vaccines, and predictive methods for infectious salmon anemia virus
11/14/2013WO2013142182A3 Combination therapy of a mek inhibitor and igf1r inhibitor
11/14/2013WO2013132274A3 Immunological methods of inhibiting gonad maturation
11/14/2013WO2013109856A3 Methods of using fgf19 modulators
11/14/2013WO2013043067A3 Dna vaccine, method of inducing the immune response, method of immunisation, antibodies specifically recognising the h5 haemagglutinin of an influenza virus and use of the dna vaccine
11/14/2013WO2012161755A9 Antagonism of the vip signaling pathway
11/14/2013WO2012118750A3 Biological markers and methods for predicting response to b-cell antagonists
11/14/2013WO2012116317A3 Combination therapies comprising anti-erbb3 agents
11/14/2013WO2012109280A3 Apoe immunotherapy
11/14/2013WO2012106669A3 Foxc1 antibodies and methods of their use
11/14/2013WO2012082470A8 The use anti-cxcl16 and anti-cxcr6 antibodies for the treatment or detecting cancer
11/14/2013US20130303735 Method of treating a pathological syndrome and a pharmaceutical agent
11/14/2013US20130302421 Compositions and methods for the prevention and treatment of autoimmune conditions
11/14/2013US20130302409 Methods and compositions for cancer immunotherapy
11/14/2013US20130302399 Anti-pcsk9 antibodies and use thereof
11/14/2013US20130302396 Co-Delivery Of Stimulatory And Inhibitory Factors To Create Temporally Stable And Spatially Restricted Zones
11/14/2013US20130302376 Allogeneic Cancer Cell-based Immunotherapy
11/14/2013US20130302374 Methods And Compositions For Dosing Of Allergens
11/14/2013US20130302373 Attenuated mycoplasma gallisepticum strains
11/14/2013US20130302372 Vaccine for protection against lawsonia intracellularis
11/14/2013US20130302371 Immunogenic Respiratory Syncytial Virus Glycoprotein-Containing VLPs and Related Compositions, Constructs, and Therapeutic Methods
11/14/2013US20130302370 Reduction of concomitant infections in pigs by the use of pcv2 antigen
11/14/2013US20130302369 Immunogenic Bordetella Bronchiseptica Compositions
11/14/2013US20130302368 Advanced Prime and Boost Vaccine
11/14/2013US20130302367 Virus vector for prime/boost vaccines, which comprises vaccinia virus vector and sendai virus vector
11/14/2013US20130302364 Highly immunogenic hiv p24 sequences
11/14/2013US20130302363 Detection of mage-a expression
1 ... 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 ... 1823